MicroRNAs: Biomarkers, Diagnostics, and Therapeutics
MicroRNAs: Biomarkers, Diagnostics, and Therapeutics
复制标题
DOI:
10.1007/978-1-4939-7046-9_4
复制
发表时间:
2017-01-01
期刊:
影响因子:
--
通讯作者:
Huang, Weili
中科院分区:
文献类型:
--
作者:
Huang, Weili
MicroRNAs (miRNAs) are small noncoding RNAs (21-23 nucleotides in length) that regulate gene expression at translational or posttranslational levels. The major regulatory mechanisms include translational repression or mRNA degradation (Filipowicz et al., Curr Opin Struct Biol 15: 331-341, 2005).Aberrant expression of miRNAs has been found to be associated with a variety of human diseases such as cancers/tumors, diabetes, viral infections, cardiovascular diseases, neurodegenerative diseases, and other diseases (Wang et al., J Cell Physiol 23: 25-30, 2016; Lawrie, MicroRNAs in medicine, 2013). The expression of miRNAs is tissue specific and can be used to identify tumor type and its origin (Mishra and Merlino, J Clin Invest 119: 2119-2123, 2009). Many investigations suggest that the miRNA-expression profiles are novel diagnostic and prognostic biomarkers for multiple human diseases. Manipulating relevant miRNA expression or function may serve as potential therapeutic strategies for different diseases.